4
Changes in Ownership
ORTHOPEDIATRICS CORP Filed Acc 0001425450-20-000047
President and CEO sold 1,876 shares at an average $46.56 ($87,351)
- President and CEO acquired 1,876 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Throdahl Mark C · President and CEO
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-05-20 | Exercise or conversion : show line 1 in the form | +670 | $30.97 | $20,750 | 155,616 | D |
| 2020-05-20 | Exercise or conversion : show line 2 in the form | +402 | $30.97 | $12,450 | 156,018 | D |
| 2020-05-20 | Exercise or conversion : show line 3 in the form | +402 | $30.97 | $12,450 | 156,420 | D |
| 2020-05-20 | Exercise or conversion : show line 4 in the form | +402 | $30.97 | $12,450 | 156,822 | D |
| 2020-05-20 | Sale : show line 5 in the form | −670 | $46.56 | $31,195 | 156,152 | D |
| 2020-05-20 | Sale : show line 6 in the form | −402 | $46.56 | $18,717 | 155,750 | D |
| 2020-05-20 | Sale : show line 7 in the form | −402 | $46.56 | $18,717 | 155,348 | D |
| 2020-05-20 | Sale : show line 8 in the form | −402 | $46.57 | $18,721 | 154,946 | D |
| Open-market sales · 1,876 sh · avg $46.56 · $87,351 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-05-20 | Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) | −670 | $30.97 | $20,750 | 0 | D |
| 2020-05-20 | Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) | −402 | $30.97 | $12,450 | 0 | D |
| 2020-05-20 | Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) | −402 | $30.97 | $12,450 | 0 | D |
| 2020-05-20 | Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) | −402 | $30.97 | $12,450 | 0 | D |
Loading xslF345X03/wf-form4_159009283321781.xml…